Geron Corporation (Nasdaq: GERN), a commercial stage biopharmaceutical company, today reported that it has granted non-statutory stock options to purc.
Castle's Compensation Committee of its Board of Directors granted restricted stock units (RSUs) as inducement material to new employees.